Zach Jonasson

Board Member

Focus at NTx

Leadership; Board Member


I am the CFO and CBO of Absci. Prior to these roles, I served as an independent member of Absci‚Äôs board of directors and as chairman of the board from April 2016 to October 2020. Previously, I was a co-founder and Managing General Partner of two venture capital firms, Phoenix Venture Partners LLC (PVP) and Convergent Ventures, where I led both firm’s venture capital investment strategies in the biotechnology sector. In those roles, I led investments in multiple companies including Absci (IPO), Valence Therapeutics (acquired by Recursion Pharmaceuticals), Sentinel Monitoring Systems (acquired by SUEZ), Totient (acquired by Absci), and ProFluent Bio, and I established fund investment partnerships with multinational corporations such as Pfizer, Corning, and L’Oreal.

Earlier in my career, I was a General Partner at Seaflower Ventures, where I led investments in companies including Serenex (acquired by Pfizer) and Metaworks (acquired by United Biosource Corporation). I have also been a co-founder of several companies, including Risk Capital Management (acquired by Towers Watson) and Crop Enhancement.

I earned my PhD in Behavioral Neuroscience from Harvard University, where I was a Sackler Scholar; an AM in Statistics from Harvard University; and a BS in Economics from the Honors Program at Georgetown University.

Interests / hobbies

Skiing, hiking, and coaching the local 4th-8th grade robotics team.